Foreign Nation Suits for Treble Damages Under the Clayton Act After Pfizer v. Government of India

After summarizing the rationale behind Pfizer, this article will trace the ramifications of the decision on American foreign, economic, and antitrust policies. Second, a suggestion for a foreign sovereign antitrust bill will then be offered. Finally, an examination of present congressional proposals will show that these proposals fail to address fully the political and economic consequences of Pfizer.